CTRI/2020/07/026462
Completed
Phase 3
A prospective, interventional, case control study to observe and assess the safety and efficacy of Unani regimen in preventing the progression of severity of the disease in hospitalized SARS-CoV2 tested positive asymptomatic /mild to moderate symptomatic COVID-19 cases, managed as per Govt of India COVID-19 management guidelines, at a COVID-19 management facility
Central Council for Research in Unani Medicine CCRUM New Delhi0 sites62 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Sponsor
- Central Council for Research in Unani Medicine CCRUM New Delhi
- Enrollment
- 62
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients of either sex aged between 18\-65 years
- •2\. Patients who have been tested positive with SARS\-CoV2 virus
- •Asymptomatic Patients
- •Patients with mild symptoms
- •Patients with moderate symptoms with respiratory rate \< 30 per minute and oxygen
- •saturation \> 90%
- •3\. Voluntariness to participate in the trial
- •USCDC classification mild to moderate, severe and critical stages of COVID\-19
- •Stage Features
- •Asymptomatic No specific clinical symptoms of COVID\-19 disease
Exclusion Criteria
- •The subject must be excluded from participating in the trial if they fulfill anyone of the criteria as
- •mentioned below:
- •1\. COVID\-19 patients with symptoms classified as severe or critical.
- •2\. Suspected COVID\-19, not tested positive for COVID\-19 by RT\-PCR
- •3\. Persons with severe primary respiratory disease or pneumonia
- •4\. Pregnant and lactating women
- •5\. Persons with serious diseases such as Cancer, Heart Disease, Stroke, Disabilities, Mental
- •illnesses, etc., and who are considered to be excluded from the study as evaluated by the
- •investigators
- •6\. COVID\-19 positive cases participating as subjects in the interventional arm of other
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A study of Ayurvedic medicine â??CoReachâ?? in COVID-19 positive patients.Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereCTRI/2021/05/033626Questt Clinicals and Ayurceuricals Pvt Ltd106
Recruiting
Not Applicable
assessment of global longitudinal strain echocardiography and brachial artery flow-mediated dilatation in patients of ANCA associated vasculitisCTRI/2022/09/045880PGIMER Chandigarh
Completed
Not Applicable
sing a wearable smartwatch diary to improve patient’s understanding of Parkinson´s diseaseParkinson´s diseaseNervous System DiseasesISRCTN17817642Västra Götaland Regional Council14
Recruiting
Not Applicable
Prospective, controlled intervention study to optimize bowel evacuation and stimulation in extremely premature infantsP07.01P07.02DRKS00024191Klinik für Neonatologie und allgemeine Pädiatrie Klinikum Kassel54
Completed
Not Applicable
PACT: Prevention of Atopy among Children in TrondheimAtopic and allergic diseases in early childhoodatopic eczemaallergic rhinoconjunctivitisasthmaSigns and SymptomsISRCTN28090297orwegian University of Science and Technology (Norway)14,000